High-frequency electrical modulation of the superior ovarian nerve as a treatment of polycystic ovary syndrome in the Rat
Author
dc.contributor.author
Pikov, Víctor
Author
dc.contributor.author
Sridhar, Arun
Author
dc.contributor.author
Lara Peñaloza, Hernán
Admission date
dc.date.accessioned
2018-09-06T19:01:30Z
Available date
dc.date.available
2018-09-06T19:01:30Z
Publication date
dc.date.issued
2018-05-01
Cita de ítem
dc.identifier.citation
Frontiers in Physiology Volume: 9 Article Number: 459
es_ES
Identifier
dc.identifier.other
10.3389/fphys.2018.00459
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/151516
Abstract
dc.description.abstract
The polycystic ovary syndrome (PCOS) is the most prevalent ovarian pathology in women, with excessive sympathetic activity in the superior ovarian nerve (SON) playing an important role in inducing the PCOS symptoms in the rats and humans. Our previous studies have shown that surgical transection of the SON can reverse the disease progression, prompting us to explore the effect of the kilohertz frequency alternating current (KHFAC) modulation as a method of reversible non-surgical suppression of the nerve activity in the rodent model of PCOS. 56 animals were randomly allocated to three groups: the Control group (n = 18), the PCOS group (n = 15), and the PCOS + KHFAC group (n = 23). The physiological, anatomical, and biochemical parameters of ovarian function were evaluated during the progression of the experimentally-induced PCOS and during long-term KHFAC modulation applied for 2-3 weeks. The KHFAC modulation has been able to reverse the pathological changes in assessed PCOS parameters, namely the irregular or absent estrous cycling, formation of ovarian cysts, reduction in the number of corpora lutea, and ovarian norepinephrine concentration. The fertility capacity was similar in the PCOS and the PCOS C KHFAC groups, indicating the safety of KHFAC modulation approach. In summary, these results suggest that the KHFAC modulation approach of suppressing the SON activity could become a useful treatment modality for PCOS and potentially other pathological ovarian conditions.